What is Targeted Medical Pharma, Inc. (TRGM)?

Targeted Medical Pharma, Inc. (TRGM) is a stock in the Healthcare sector, Medical - Pharmaceuticals industry. View full analysis on Stocks360.

What is the current price of TRGM?

The current price of TRGM is $0.00. Prices are updated in real time on Stocks360.

What is TRGM's price-to-earnings (PE) ratio?

TRGM's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is TRGM's market capitalization?

TRGM's market capitalization is $302.00, placing it in the small-cap tier.

Targeted Medical Pharma, Inc. (TRGM)

Stock analysis · OTC · Healthcare · Medical - Pharmaceuticals

$0.00

Market Cap

$302.00

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.03

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.02

Avg Volume

N/A

Volume

11.68K

Targeted Medical Pharma, Inc. (TRGM) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $302.00. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-31 · $0.00 2026-10-26 · $0.00 (-90.00%)

Earnings

Most Recent

Aug 14, 2014

EPS $-0.02 vs est. $-0.02

Beat by $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy. The company also provides a proprietary billing process and supporting software (PDRx) that facilitates physician dispensing; provides inventory control; and assists regulatory reporting. In addition, it offers billing and collection services relating to its products on behalf of dispensing physician clients to private insurance and workers’ compensation insurance. Targeted Medical Pharma, Inc. distributes its products through a network of distributors and an internal sales force that sells products directly…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.00×
P/B	-0.00×
P/FCF (TTM)	-0.00×
EV / EBITDA	-3.13×
EV / Sales	0.99×
Earnings Yield	-1118305.72%
Free Cash Flow Yield	-423383.11%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$5.21M
Revenue (TTM)	$5.26M
Net Income (TTM)	-$3.38M
Free Cash Flow (TTM)	-$105.05K
Net Debt	$5.21M
Working Capital	-$13.84M
Gross Margin	60.17%
Operating Margin	-38.58%
Net Margin	-57.86%
Return on Equity	26.62%
Return on Invested Capital	26.62%